Cargando…
Ustekinumab for Successful Treatment of Refractory Esophageal Crohn’s Disease
Esophageal involvement in Crohn’s disease is rare. We present a case of refractory esophageal Crohn’s disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn’s disease. There are no prior reports on the successful use of ustekinumab i...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Gastroenterology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748197/ https://www.ncbi.nlm.nih.gov/pubmed/26958561 http://dx.doi.org/10.14309/crj.2016.15 |